% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • barrel.denis barrel.denis Nov 28, 2012 5:56 PM Flag

    Here's why I personally prefer to only SHORT SRPT

    The problem is that a 2000 patients spending $300,000 per year, and assmuing a 50% profit margin, you have a company earning $300 MM per year. Even at a p/e of 5, the market cap is $1.5 billion, double the current market cap.
    So, the only reason to short this is if you don't believe the drug works IMO.

40.81-3.73(-8.37%)Oct 27 4:00 PMEDT